Related Experiment Video
Updated: Jan 22, 2026

11:18
Generation of Comprehensive Thoracic Oncology Database - Tool for Translational Research
Published on: January 22, 2011
16.5K
Creating the Next Generation of Translational Geroscientists
John C Newman1, Julie L Sokoloski2, Paul D Robbins3
1Buck Institute for Research on Aging, and, University of California San Francisco Division of Geriatrics, Novato, California.
Journal of the American Geriatrics Society
|July 10, 2019
Summary
Developing new geroscience therapeutics requires specialized clinical investigators. This study outlines a consensus for training programs to build a skilled workforce for early-stage geroscience trials.
Area of Science:
- Gerontology and Geriatric Medicine
- Translational Research
- Clinical Trial Design
Background:
- Advances in aging research offer promising geroscience therapeutics for age-related diseases.
- A significant challenge is the limited number of investigators skilled in early-stage geroscience clinical trials.
- Existing training pathways are inadequate to meet the growing need for such expertise.
Purpose of the Study:
- To address the bottleneck in early-stage geroscience clinical trials by developing a strategy for training investigators.
- To establish consensus on the necessary competencies, candidate identification, credentialing, and program implementation for translational geroscience training.
- To foster a multidisciplinary research environment for developing transformative aging therapeutics.
Main Methods:
- Convened experts (basic scientists, gerontologists, clinicians) at the National Institute on Aging R24 Geroscience Network retreat.
- Discussed identification, recruitment, and training of investigators for early-phase geroscience trials.
- Developed a consensus on training program structure, content, and implementation.
Main Results:
- Identified essential subject domains and competencies for geroscience trial investigators.
- Proposed strategies for identifying and credentialing suitable trainees.
- Emphasized the role of foundations and funding agencies in supporting training programs.
- Highlighted the need for a diverse cadre of investigators beyond geriatricians.
Conclusions:
- Translational geroscience training programs are crucial for developing investigators capable of conducting early-stage trials.
- Such programs can cultivate a supportive culture for multidisciplinary aging research.
- This initiative aims to accelerate the translation of innovative geroscience concepts into effective therapeutics for older adults, enhancing health and independence.
Related Concept Videos
Translation
155.8K
Lesson: Translation
Translation is the process of synthesizing proteins from the genetic information carried by messenger RNA (mRNA). Following transcription, it constitutes the final step in the expression of genes. This process is carried out by ribosomes, complexes of protein and specialized RNA molecules. Ribosomes, transfer RNA (tRNA), and other proteins produce a chain of amino acids—the polypeptide—as the end product of translation.
Translation Produces the Building Blocks of...
Translation is the process of synthesizing proteins from the genetic information carried by messenger RNA (mRNA). Following transcription, it constitutes the final step in the expression of genes. This process is carried out by ribosomes, complexes of protein and specialized RNA molecules. Ribosomes, transfer RNA (tRNA), and other proteins produce a chain of amino acids—the polypeptide—as the end product of translation.
Translation Produces the Building Blocks of...
155.8K
Translation
17.6K
Translation is the process of synthesizing proteins from the genetic information carried by messenger RNA (mRNA). Following transcription, it constitutes the final step in the expression of genes. This process is carried out by ribosomes, complexes of protein and specialized RNA molecules. Ribosomes, transfer RNA (tRNA), and other proteins produce a chain of amino acids—the polypeptide—as the end product of translation.
Translation Produces the Building Blocks of Life
Proteins are...
Translation Produces the Building Blocks of Life
Proteins are...
17.6K
Initiation of Translation
38.4K
Initiating translation is complex because it involves multiple molecules. Initiator tRNA, ribosomal subunits, and eukaryotic initiation factors (eIFs) are all required to assemble on the initiation codon of mRNA. This process consists of several steps that are mediated by different eIFs.
First, the initiator tRNA must be selected from the pool of elongator tRNAs by eukaryotic initiation factor 2 (eIF2). The initiator tRNA (Met-tRNAi) has conserved sequence elements including modified bases at...
First, the initiator tRNA must be selected from the pool of elongator tRNAs by eukaryotic initiation factor 2 (eIF2). The initiator tRNA (Met-tRNAi) has conserved sequence elements including modified bases at...
38.4K
Termination of Translation
27.5K
The large ribosomal subunit has several important structures essential to translation. These include the peptidyl transferase center (PTC) - which is the site where the peptide bond is formed - and a large, internal, water-filled tube through which the nascent polypeptide moves. This latter structure is called the Peptide Exit Tunnel, and it begins at the PTC and spans the body of the large ribosomal subunit. During translation, as the nascent polypeptide chain is synthesized, it passes through...
27.5K
Termination of Translation
6.6K
6.6K
Improving Translational Accuracy
14.1K
Base complementarity between the three base pairs of mRNA codon and the tRNA anticodon is not a failsafe mechanism. Inaccuracies can range from a single mismatch to no correct base pairing at all. The free energy difference between the correct and nearly correct base pairs can be as small as 3 kcal/ mol. With complementarity being the only proofreading step, the estimated error frequency would be one wrong amino acid in every 100 amino acids incorporated. However, error frequencies observed in...
14.1K

